Burt, Richard K. https://orcid.org/0000-0002-0922-4145
Balabanov, Roumen
Tavee, Jinny
Han, Xiaoqiang
Sufit, Robert
Ajroud-Driss, Senda
Jovanovic, Borko
Quigley, Kathleen
Arnautovic, Indira
Helenowski, Irene
Sharrack, Basil
Article History
Received: 4 May 2020
Revised: 15 June 2020
Accepted: 18 June 2020
First Online: 27 June 2020
Compliance with ethical standards
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest except the following author. Rouman Balabanov—Scientific Advisory Boards-Biogen, Sanofi-Genzyme, Genentech, Alexion Speakers' Bureaus–Biogen Idec, Sanofi-Genzyme.
: Patients enrolled in this open-label prospective study were treated at Northwestern Memorial Hospital (Chicago, Illinois, USA) on an IRB and FDA approved protocol ( NCT00278629) and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All persons gave their informed consent prior to their inclusion in the study.